Stock Detail
CRYOLIFE INC
Drugs
CRY @ Yahoo Finance | CRY Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $4.67 | $4.78 | $-0.20 | -4.11% | 0.00 | $4.87 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $4.78 | $4.65 | 126,203 | 131.41M | 101,889 | 16.79 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 4.83 | 4.75 | 4.70 | 4.62 | 4.57 |
Stock Profile
CryoLife, Inc. engages in the preservation and distribution of human tissues for cardiovascular, vascular, and orthopedic transplant applications. The company also engages in the development and commercialization of implantable medical devices, including its BioGlue Surgical Adhesive (BioGlue); the CryoLife-O'Brien aortic heart valve, a glutaraldehyde-fixed stentless porcine heart valve; and SynerGraft processed bovine vascular grafts for use as arteriovenous access devices. It distributes preserved human cardiovascular, vascular, and orthopedic tissue in the United States, Canada, and Europe. CryoLife distributes BioGlue in the United States and Europe for vascular applications, as well as for pulmonary indications, such as the repair of air leaks in lungs, and soft tissue repair procedures. The company markets the SynerGraft processed bovine vascular graft in Europe and the Middle East. It markets its CryoLife-O'Brien aortic heart valve in Europe and certain other territories outside the U.S. CryoLife was founded in 1984. The company is headquartered in Kennesaw, Georgia.